Meinox Pharma Technologies (Meinox İlaç Teknolojileri A.Ş.) was established in 2019 with the support of TUBITAK BiGG SME program.
Meinox focuses on development and marketing of novel, drug-like, targeted and high-level pharmaceuticals.
Meinox aims to develop a library of first-in-class, selective small molecule inhibitors of MEINOX family, in particular oncogenic MEIS, PBX, TGIF2 proteins and their co-factor HOXA9.
Meinox was awarded as #1 in Turkey (of 137 SMEs) and #17 in Europe (of 3275 SMEs) in EU Horizon2020 SME Instrument Phase I program. Meinox received the biggest awards given by Istanbul Chamber of Industry and Elginkan Foundation at Bigbang 2019 challenge.
This SME has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 888430
MEINOX announces the support of the highly competitive European Union’s Horizon 2020 research and innovation program for Small to Medium-Sized Enterprise (SME) for the marketing of MEIS inhibitors. The MEINOX develops next generation therapeutics to fight cancer by novel small molecule MEIS inhibitors. In phase 1, MEINOX is awarded EUR 50'000 and mentored by EU industry experts to compile a feasibility study for a phase 2 proposal (upto 2.5M Euros). The team thanks the European Commission for the award received.
The European Union’s Horizon 2020 research and innovation program supports breakthrough innovation projects with a market-creating potential. The SME instrument boosts fast company growth and market-creating innovation thanks to staged funding and ramped up business acceleration services.
Dr. Fatih Kocabas, established Meinox to develop novel personalized therapeutics based on MEIS inhibitors
Our team includes experts in project management, quality control, R&D coordinator, product and marketing manager.
Our Advisory Board consists of academic experts and business developers.
Meinox is looking for motivated and experienced professionals in drug development.
Meinox is always searching for possibilities that could support the company and the product pipeline.
We welcome strategic partnerships with renowned biotech and pharmaceutical companies.
Web sitesi trafiğini analiz etmek ve web sitesi deneyiminizi optimize etmek amacıyla çerezler kullanıyoruz. Çerez kullanımımızı kabul ettiğinizde, verileriniz tüm diğer kullanıcı verileriyle birlikte derlenir.